Cilengitide

TypeName: Business Offer

Category:

Offer Date:2019/07/13

Country: United States

Summary: Cilengitide is a cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. It is being studied for the treatment of glioblastoma. https://www.bocsci.com/cilengitide-cas-188968-51-6-item-86472.html

Description:

OfferId: 4898

Name:Alex Brown

Telphone:

Email:[email protected]

No Man

Cilengitide

Advertising